Merck & Co., Inc. KYMR Holdings History
Number of Shares
772,165.00
Current Holdings Value*
$21.13 Mil
% of Portfolio
12.86%
Total Estimate Gain
$818,494.90
% of Total Estimate Gain
2.35%
Merck & Co., Inc.'s Kymera Therapeutics Inc Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 772,165.00 shares of Kymera Therapeutics Inc(KYMR), totaling $21.13 Mil. This investment constitutes 12.86% of their stock portfolio, and Merck & Co., Inc. now holds 1.19% of the outstanding Kymera Therapeutics Inc(KYMR) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and KYMR's current price of $46.20, Merck & Co., Inc.'s estimated gain on his KYMR holdings is $818,494.90, reflecting a 2.35% gain to date.
Merck & Co., Inc. KYMR ($46.20) Holding Chart
Merck & Co., Inc. KYMR ($46.20) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1